What was recalled
The U.S. Food and Drug Administration (FDA) has issued a Class II recall affecting a specific pharmaceutical product distributed by Golden State Medical Supply Inc., also known as GSMS, Incorporated. This company is based in Camarillo, California, and is responsible for marketing the affected medication nationwide across the United States. The item at the center of this recall is Prasugrel Hydrochloride (HCl) Tablets, USP, specifically the 10mg strength. These are prescription-only medications, meaning they are not available over-the-counter and require a doctor’s authorization to obtain.
The recall targets a single lot of this medication, identified by Lot Number GS062298. Each bottle contains 30 tablets and is packaged in a standard container intended for retail or pharmacy distribution. The product is marketed under the brand name Golden State Medical. For those who need to verify their medication, the National Drug Code (NDC) associated with this specific 30-count bottle configuration is 51407-445-30. It is important to note that while the manufacturer has not explicitly stated a monetary value or total unit count in the provided notification, the scope of the recall is defined by this specific lot number and expiration date rather than a broad batch size.
The affected tablets have an expiration date of September 30, 2026. The distribution pattern for this recalled product covers the entire United States, meaning these bottles could be found in pharmacies, hospitals, or clinics in any state. Although the manufacturer is located in California, the recall is not limited to that region; it applies to any consumer or healthcare provider nationwide who may have received this specific lot from GSMS, Incorporated. The notification date for this recall was August 21, 2026, marking the official start of the withdrawal process initiated by the manufacturer due to quality control issues.
This recall is classified as a Class II recall by the FDA. While the term "Class II" might sound technical, it generally indicates a situation where the use of the product could cause temporary or medically reversible health problems, or where the probability of serious adverse health consequences is remote. However, because this involves a prescription drug used for cardiovascular health, even a Class II recall demands immediate attention and verification to ensure patient safety. The manufacturer has taken the proactive step of notifying relevant parties to remove these specific units from the supply chain.
If you have been prescribed Prasugrel HCI 10mg by Golden State Medical, do not panic, but do act promptly. Check your bottle immediately for the lot number GS062298 and the NDC 51407-445-30. If these numbers match, you are in possession of a product that has failed dissolution specifications, which is the primary reason for this recall. The manufacturer has identified that the tablets do not meet the required standards for how they break down and release their active ingredients in the body.
It is crucial to understand that this recall is specific to the lot GS062298. Other lots of Prasugrel HCI from Golden State Medical or other manufacturers are not necessarily affected unless specified by a separate notice. Therefore, precise identification using the lot number and expiration date is your first line of defense in determining whether you need to take action.
The hazard, explained
At the heart of this recall is a subtle but significant manufacturing inconsistency: the Prasugrel HCI tablets have failed to meet established dissolution specifications. To understand why this matters, it helps to look at what happens when you swallow a pill. A tablet is not just a block of powder; it is engineered to break down in your stomach and intestines at a specific rate. This process, called dissolution, is the critical bridge between swallowing a medication and your body actually using it. For a drug like Prasugrel, which is used to prevent blood clots in patients with acute coronary syndrome, the timing and amount of absorption are not just matters of convenience—they are matters of precise clinical efficacy.
Dissolution specifications are strict standards set by regulatory bodies to ensure that every single tablet in a batch performs consistently. When a lot fails these specifications, it means the tablets did not release their active ingredient at the expected rate or in the expected amount. In practical terms, this creates an unpredictable delivery system. You might take a pill expecting a full dose to help keep your blood from clotting excessively, but due to the failed dissolution, your body may absorb significantly less of the drug than intended. Conversely, in some cases of dissolution failure, the drug might release too quickly or unevenly, leading to spikes in concentration that can increase the risk of side effects without providing sustained therapeutic benefit.
The specific danger here is tied to the nature of Prasugrel itself. As an antiplatelet agent, its primary job is to stop blood platelets from sticking together and forming clots. If the dissolution fails such that too little drug enters your bloodstream, you are effectively under-dosing yourself. For someone with a heart condition or who has recently undergone a stent placement, this reduced efficacy can be dangerous. It means the protective barrier against clot formation is weaker than it should be, potentially increasing the risk of serious cardiovascular events like a heart attack or stroke. The body cannot compensate for a missing dose in real-time; if the pill doesn’t deliver the drug properly, the physiological protection simply isn’t there.
It is important to note that this issue is rooted in the manufacturing process rather than contamination or toxicity. The tablets themselves may look normal, and they do not contain harmful substances. However, their internal structure or coating may have been altered during production, affecting how they interact with stomach acid and intestinal fluids. This is why it is impossible to tell if a specific bottle is part of this recall by looking at the pills. The failure is microscopic and chemical, occurring at the molecular level during the disintegration phase. Because the hazard lies in the reliability of the drug delivery, even one tablet from this affected lot cannot be considered safe for its intended medical purpose. This unpredictability is exactly why the FDA has classified this as a Class II recall, indicating that while use of the product may cause temporary health problems or pose a slight threat of a serious nature, it is not immediately life-threatening in the same way as contamination with a poison would be. Still, for a medication that manages critical heart health, reliability is non-negotiable.
Who is most at risk
The individuals directly affected by this recall are those who have been prescribed Prasugrel hydrochloride (HCl) 10 mg tablets by a healthcare provider and purchased the specific inventory distributed by Golden State Medical Supply Inc. Because this medication is available only by prescription, the group of people at risk is defined strictly by their current treatment plan for cardiovascular conditions. Prasugrel is an antiplatelet agent, meaning it works by preventing blood platelets from clumping together to form clots. It is typically prescribed to patients who have had a recent heart attack or are undergoing percutaneous coronary intervention (PCI), such as having a stent placed in a narrowed artery. Therefore, the primary demographic at risk consists of adults managing acute coronary syndromes or complex heart disease. These are not casual users; they are individuals relying on this medication to maintain blood flow and prevent life-threatening events like future heart attacks or strokes.
The specific nature of this recall introduces a unique layer of vulnerability that goes beyond the typical side effects of the drug. The hazard here is not that the drug contains a toxic substance, but rather that it may fail to dissolve properly in the body. For patients with compromised cardiovascular health, consistent and predictable medication delivery is critical. If the tablets do not dissolve as intended due to failed dissolution specifications, the body may not absorb the full dose of prasugrel. This creates a situation where a patient believes they are protected by their medication, but their blood is actually more prone to clotting than expected. For elderly patients, who often take multiple medications and may have slower metabolic rates, this unpredictability can be particularly dangerous. It can lead to a false sense of security while their underlying heart condition remains inadequately managed.
While the recall notice does not specify that children are at risk, it is important to note that because this is an Rx-only medication for serious heart conditions, it is extremely unlikely to be found in households with young children. However, the elderly population remains the most vulnerable subgroup within the patient category. Older adults are more likely to have renal or hepatic impairment, which can already affect how drugs are processed in the body. Adding the variable of inconsistent drug dissolution on top of age-related physiological changes increases the uncertainty of their treatment outcome. These patients rely on their doctors and pharmacists to provide reliable care; when a batch fails quality control, it disrupts that trust at a moment when medical consistency is most vital. Consequently, the risk is highest for those who take this specific lot regularly without realizing the potential for sub-therapeutic dosing. They are not just risking a minor inconvenience; they are risking the efficacy of a critical life-saving therapy during a vulnerable period of their cardiac care journey.
How to tell if you have the recalled item
Locating the specific details on your medication bottle is the most critical step in this process because recalls are almost always targeted at particular batches rather than every single unit of a drug ever produced. If you simply know that you take Prasugrel HCl, that information alone is not enough to determine if your supply is part of this recall. You must physically inspect the packaging to match several specific identifiers against the official notification from the FDA and Golden State Medical Supply Inc. This process requires patience and attention to detail, but it is the only way to be certain you are safe.
First, look at the primary label on the bottle itself. You need to verify that you have a 30-count bottle of Prasugrel HCl, Tablets, USP, 10mg. The brand name printed on the packaging must read "Golden State Medical." It is important to note that while the manufacturer is Golden State Medical Supply Inc., the entity marketing the product is GSMS, Incorporated, located in Camarillo, California. If your bottle was distributed by a different pharmacy or holds a different brand name, it is likely not part of this specific recall, though you should always verify with your pharmacist if you are unsure.
The most definitive proof, however, lies in the National Drug Code (NDC) and the Lot Number. These codes are unique identifiers assigned to every batch of pharmaceuticals. You must find the NDC listed as 51407-445-30 on your bottle. Next, locate the Lot number, which for this recall is specifically GS062298. If your lot number differs from GS062298, your medication is not affected by this specific dissolution failure notification. Additionally, check the expiration date printed on the label. The recalled product has an expiration date of 09/30/2026. While an expired date alone does not confirm a recall, matching this date alongside the correct lot number strengthens the likelihood that your bottle is part of the affected distribution.
You should also consider where and when you purchased the medication. This recall involves products distributed nationwide across the United States. If you bought the drug from a major national chain, a local independent pharmacy, or through mail order within the U.S., it could potentially be included in this batch. However, location of purchase is secondary to the physical codes on the bottle. Do not rely on memory or general descriptions. Take your bottle out, read the NDC and Lot number carefully, and compare them exactly to the information provided by the FDA. If any part of that data does not match—especially the lot number GS062298—you can likely rest easy that your specific supply is safe. If it matches, do not panic, but do follow the next steps immediately.
What to do — step by step
If you have been prescribed Prasugrel HCI tablets by Golden State Medical under the brand name "Golden State Medical," specifically the 10mg strength packaged in 30-count bottles, it is crucial that you take immediate, careful action. The primary concern here is that the medication may not dissolve properly in your body. When a tablet fails to dissolve as intended, it means your body might not be absorbing the correct amount of the drug. For a medication like Prasugrel, which is used to prevent blood clots, inconsistent absorption can lead to serious health risks, ranging from the treatment being ineffective to unpredictable side effects.
Your first and most important step is to stop taking the medication immediately. Do not wait for your next scheduled dose. If you simply skip a dose without contacting your healthcare provider, you may be left without necessary protection against clotting events. Therefore, your second step is to contact your prescribing doctor or pharmacist right away. Explain that you have received a Class II recall notice for this specific lot of Prasugrel HCI. They need to know this so they can evaluate your current health status and provide you with a new, safe prescription from a different manufacturer or a different lot number that has passed quality checks. Do not attempt to self-medicate or switch brands without professional guidance.
Next, you need to identify exactly which product you have. Look at the bottle label for the National Drug Code (NDC) 51407-445-30 and verify that it matches the recalled Lot # GS062298 with an expiration date of 09/30/2026. If your bottle does not match these specific details, it is likely not part of this recall, but you should still confirm with your pharmacist to be absolutely certain.
Regarding the physical product itself, please note that the official FDA notification for this specific recall from Golden State Medical Supply Inc. does not currently state a specific remedy, such as a direct return address or a refund process from the manufacturer. This is somewhat unusual but not unheard of in pharmaceutical recalls where the focus is on removing the product from the market rather than processing individual consumer returns. Because the remedy is not explicitly stated, you should ask your pharmacist about their protocol for disposing of recalled medications. Many pharmacies have secure take-back programs or can advise you on safe disposal methods to ensure the medication does not end up in landfills or water sources.
Finally, keep a record of your communication with your healthcare provider and any steps you took regarding the medication. This documentation can be helpful if you experience any health issues related to the inconsistent dosage during the time you were taking the recalled product. Stay calm, but act promptly. Your safety is the priority, and your medical team is there to help you transition to a safe, effective alternative without interruption in your care.
Your refund, repair, or replacement options
When a medication recall occurs, the most pressing question is often, "What happens next?" In this specific instance involving Golden State Medical Supply Inc., the remedy details are not explicitly stated in the official notification. This absence of specific instructions can feel unsettling, but it is not uncommon in Class II recalls where the primary focus remains on removing the product from the market to prevent potential exposure rather than immediately processing individual returns. Because the recall was initiated due to failed dissolution specifications—a quality control issue where the tablet may not break down properly in the body—the manufacturer’s immediate priority is likely the retrieval of the inventory rather than managing consumer logistics. Therefore, you should not assume a standard refund or replacement process is automatically underway without taking proactive steps. Since the official record does not list a specific contact number, email address, or web portal for consumers, your first step must be to locate the documentation that accompanied your prescription. Check the pharmacy receipt, the original packaging insert, or any correspondence you received when the medication was dispensed. These documents often contain the specific customer service line for the distributor (GSMS, Incorporated) or the retail pharmacy where you picked up the drug. If you cannot find this information, do not guess. Instead, contact the pharmacy directly. Pharmacies are legally required to maintain records of their suppliers and can often facilitate the return process on your behalf. They will know whether they have been instructed to destroy the stock, return it to the distributor for credit, or issue a direct refund to your payment method. It is important to understand that "repair" is not an applicable option for pharmaceutical products. You cannot fix a tablet that has failed dissolution testing. The only valid options are either a replacement with a verified, good-quality batch or a financial refund. If you have already consumed any of the tablets from lot GS062298, do not expect a refund for those specific units in the traditional sense. Instead, your focus should be on ensuring your current medical treatment is uninterrupted. Contact your healthcare provider immediately to discuss whether you need a new prescription with a different lot number or from a different manufacturer. Your doctor may also want to monitor you for any efficacy issues, as the failed dissolution could mean the drug did not work as intended. If you are planning to return the unopened bottle, keep it in its original packaging until you speak with your pharmacist. Do not dispose of it in household trash or flush it down the toilet unless specifically instructed by a medical professional or local waste authority, as improper disposal can harm the environment. When you do reach out to the pharmacy or distributor, have your lot number (GS062298) and expiration date (09/30/2026) ready. This specific identification is crucial because it confirms exactly which batch of product you possess, allowing them to verify against the recall list quickly and accurately. While the official notice does not specify a deadline for returns, acting promptly ensures that your pharmacy can adjust their inventory records and potentially expedite any credit or refund process they are authorized to provide.What can happen if you ignore it
When a medication is recalled due to failed dissolution specifications, the immediate concern might seem abstract, but the physiological reality is quite concrete. Prasugrel is a potent antiplatelet agent, often prescribed to prevent blood clots in patients who have recently experienced a heart attack or undergone certain cardiac procedures. Its primary function is to keep your blood flowing smoothly by inhibiting platelets from sticking together. When the drug fails to dissolve properly, it does not mean the tablet becomes inert; rather, it means the release of the active ingredient into your bloodstream becomes unpredictable and unreliable.
If you continue taking this specific lot without realizing its quality has failed, you are essentially gambling with your cardiovascular health in a way that offers no benefit. The most significant risk is therapeutic failure. Because the tablet did not dissolve according to established standards, the amount of Prasugrel that actually enters your system may be lower than the prescribed 10mg dose. This sub-therapeutic exposure means your blood may not receive the necessary protection against clot formation. For someone relying on this medication to keep their heart vessels clear, a failure to absorb the full dose significantly increases the likelihood of developing a new clot. In clinical terms, this translates to a heightened risk of recurrent heart attack, stroke, or stent thrombosis—events that can be sudden, severe, and potentially fatal.
It is also important to understand that dissolution failures do not always result in "under-dosing." In some cases, the tablet may dissolve too quickly, dumping the entire dose into your stomach at once rather than releasing it gradually. This rapid absorption can lead to unexpectedly high levels of the drug in your blood, drastically increasing the risk of bleeding complications. While the recall notice from Golden State Medical Supply Inc. does not report specific incidents of injury or adverse events linked to this lot, the potential for harm is inherent in the nature of the defect. You might experience unusual bruising, nosebleeds, or gastrointestinal bleeding if the drug levels spike unexpectedly.
Ignoring the recall also means you are leaving your condition unmanaged without a clear plan. The gap in effective treatment—whether due to too little drug absorbing or too much causing bleeding—creates a window of vulnerability. Your body is attempting to heal or maintain stability, but the tool you are using to support that process is broken. Continuing to use the product delays the time you spend with your healthcare provider who can switch you to a verified, safe supply. In the context of cardiac care, every day spent on an ineffective medication is a day where your heart is unprotected against the very events the drug was designed to prevent. The consequence is not just a wasted bottle; it is a tangible risk to your long-term health and safety.
Staying safe: broader tips
While this specific recall highlights the importance of monitoring pharmaceutical supply chains, maintaining your overall health safety often comes down to establishing reliable habits and staying informed. Medications are a critical part of managing chronic conditions, such as cardiovascular issues that Prasugrel is designed to address, but they require careful handling from the moment you pick them up at the pharmacy until the bottle is empty. One of the most effective ways to ensure medication safety is to verify that your storage environment protects the integrity of the pills. Many prescription tablets are sensitive to moisture, heat, and light. Storing them in a cool, dry place away from direct sunlight—typically in their original container with the lid tightly closed—helps preserve their chemical stability. Avoid storing medications in bathrooms or near kitchen sinks where humidity levels fluctuate dramatically, as this can accelerate degradation even before the expiration date arrives.
Beyond physical storage, proactive communication with your healthcare provider is a vital layer of protection. Pharmacists and doctors are your first line of defense against potential errors or supply issues. Always ask your pharmacist about the manufacturer and lot number if you have questions about a new prescription, especially if you notice any changes in the pill’s appearance, such as unusual discoloration or crumbling. Furthermore, consider setting up alerts with the U.S. Food and Drug Administration (FDA) through their MedWatch program. This free service allows you to receive immediate notifications about safety warnings, voluntary recalls, and new drug approvals that might affect your specific health regimen. By staying connected to these official channels, you empower yourself to act quickly if a similar situation arises in the future.
Finally, never hesitate to report any adverse effects or quality concerns directly to the manufacturer or the FDA’s MedWatch program. Your feedback contributes to a broader network of post-market surveillance that helps regulators identify patterns that might not be visible through isolated incidents. For those managing long-term prescriptions, it is wise to keep a simple log of your medications, including purchase dates and lot numbers if provided. This practice not only aids in inventory management but also simplifies the process of verification should a recall ever impact your specific batch. By combining vigilant storage practices with active engagement in official safety networks, you create a robust personal safety net that complements professional medical oversight.